EWTX

Edgewise Therapeutics, Inc.

Export transactions ↓

Tapewire entity: 3965
SEC CIK: 0001710072
Parsed reports: 201

Last 12 months

Inside the activity.

1 purchase rows · 33 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Monthly counts

Month	Purchases	Sales
Nov 2025	1	1
Dec 2025	0	0
Jan 2026	0	5
Feb 2026	0	0
Mar 2026	0	3
Apr 2026	0	1
May 2026	0	2
Jun 2026	0	0
Jul 2026	0	2
Aug 2026	0	19
Sep 2026	0	0
Oct 2026	0	0

Latest available

Insider transactions

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Owner / reported role	Activity / security	Shares / units	Reported price	Reported value	Details
March 30, 2021 Filed Mar 31, 2021 23:11 UTC	Thompson Peter A.Director · 10% owner	ConversionCommon Stock	12,730,036	$0.00	$0.00	Disclosure SEC source: 0001209191-21-023868 · doc4.xml · nonDerivative · entry 1 Thompson Peter A. · CIK 0001357522 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 13,046,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series B-2 Preferred Stock and Series C Preferred Stock converted into one share of the Issuer's Common Stock immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date. F2 · ownership.nature: These securities are held of record by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI. OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VI. The Reporting Person is an employee of OrbiMed Advisors. By virtue of such relationship, OrbiMed Advisors and GP VI may be deemed to have voting power and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. Read SEC document
March 30, 2021 Filed Mar 31, 2021 20:36 UTC	NOVO HOLDINGS A/S10% owner	ConversionSERIES C CONVERTIBLE PREFERRED STOCK · Derivative	650,328	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-023779 · doc4.xml · derivative · entry 5 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 650,328 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. F1 · price: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.exercise_date: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.expiration_date: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. Read SEC document
March 30, 2021 Filed Mar 31, 2021 20:36 UTC	NOVO HOLDINGS A/S10% owner	ConversionSERIES B-2 CONVERTIBLE PREFERRED STOCK · Derivative	1,952,439	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-023779 · doc4.xml · derivative · entry 4 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 1,952,439 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. F1 · price: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.exercise_date: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.expiration_date: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. Read SEC document
March 30, 2021 Filed Mar 31, 2021 20:36 UTC	NOVO HOLDINGS A/S10% owner	ConversionSERIES B-1 CONVERTIBLE PREFERRED STOCK · Derivative	2,359,440	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-023779 · doc4.xml · derivative · entry 3 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 2,359,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. F1 · price: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.exercise_date: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.expiration_date: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. Read SEC document
March 30, 2021 Filed Mar 31, 2021 20:36 UTC	NOVO HOLDINGS A/S10% owner	PurchaseCOMMON STOCK	625,000	$16.00	$10,000,000.00	Disclosure SEC source: 0001209191-21-023779 · doc4.xml · nonDerivative · entry 2 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,587,207 F2 · price: Represents a purchase from the underwriters in the Issuer's initial public offering. Read SEC document
March 30, 2021 Filed Mar 31, 2021 20:36 UTC	NOVO HOLDINGS A/S10% owner	ConversionCOMMON STOCK	4,962,207	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-023779 · doc4.xml · nonDerivative · entry 1 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,962,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into one share of common stock upon the completion of the Issuer's initial public offering. These shares have no expiration date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.